Eligard Depot 22.5mg Injection

About

Eligard Depot 22.5mg Injection contains leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist. It functions by initially stimulating and then desensitizing the GnRH receptors in the pituitary gland. This leads to a sustained reduction in the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which subsequently lowers the production of testosterone in men. This mechanism is primarily utilized in the management of hormone-sensitive conditions, particularly advanced prostate cancer, by achieving a state of medical castration.

The depot formulation ensures a prolonged and consistent release of leuprolide acetate, providing sustained therapeutic effects over an extended period. This helps to suppress tumor growth and alleviate symptoms associated with prostate cancer. Regular administration by a healthcare professional is crucial for maintaining optimal hormone suppression and therapeutic outcomes. Patients should be monitored for potential side effects and treatment efficacy throughout the course of therapy.

Uses

• Advanced prostate cancer
• Endometriosis (off-label in some regions)
• Uterine fibroids (off-label in some regions)
• Precocious puberty (different formulations)

Directions For Use

Administered as a subcutaneous injection by a healthcare professional, typically once every 3 months for the 22.5mg dose.

Benefits

• Reduces testosterone levels effectively
• Slows the progression of prostate cancer
• Helps manage symptoms associated with prostate cancer
• Convenient long-acting injection
• Provides sustained hormone suppression
• Effective in hormone-sensitive conditions

Side Effects

• Hot flashes
• Injection site pain/redness
• Fatigue
• Headache
• Decreased libido
• Erectile dysfunction
• Bone density loss
• Muscle weakness
• Mood changes
• Weight gain
• Joint pain
• Peripheral edema

Safety Measures

• Alcohol - No specific interaction with alcohol, but general moderation is advised.
• Pregnancy - Contraindicated in pregnancy due to potential for fetal harm.
• Breastfeeding - Not recommended during breastfeeding due to potential for adverse effects on the infant.
• Liver - Use with caution in patients with liver impairment; monitor liver function.
• Kidney - No specific dose adjustment needed for renal impairment, but monitor overall health.
• Lung - No specific contraindications related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.